Sarah Boyce brings to Avidity extensive experience in the life sciences industry, where she has built global organizations and brought to patients a number of innovative therapies, including Tegsedi®, Waylivra®,
Sarah Boyce brings to Avidity extensive experience in the life sciences industry, where she has built global organizations and brought to patients a number of innovative therapies, including Tegsedi®, Waylivra®,
As president and then CEO of Oracle, one of the worlds largest software companies, Safra Catz has helped shape the present and future of the computer world. Born in Israel,
As president and then CEO of Oracle, one of the worlds largest software companies, Safra Catz has helped shape the present and future of the computer world. Born in Israel,
Priscilla Sims Brown is the CEO of Amalgamated Financial Corp., a leading provider of financial services with a strong focus on social responsibility and impact investing. Browns leadership is defined
Priscilla Sims Brown is the CEO of Amalgamated Financial Corp., a leading provider of financial services with a strong focus on social responsibility and impact investing. Browns leadership is defined
Rachel E. Haurwitz, Ph.D., is the CEO of Caribou Biosciences, Inc., a biotechnology company specializing in CRISPR-based gene editing technologies. Dr. Haurwitzs leadership is characterized by her commitment to advancing
Rachel E. Haurwitz, Ph.D., is the CEO of Caribou Biosciences, Inc., a biotechnology company specializing in CRISPR-based gene editing technologies. Dr. Haurwitzs leadership is characterized by her commitment to advancing
Rachel McMinn, Ph.D., is the CEO of Neurogene Inc., a biopharmaceutical company focused on developing innovative gene therapies for neurological disorders. Dr. McMinns leadership is marked by her dedication to
Rachel McMinn, Ph.D., is the CEO of Neurogene Inc., a biopharmaceutical company focused on developing innovative gene therapies for neurological disorders. Dr. McMinns leadership is marked by her dedication to
Reshma is the Chief Executive Officer and President at Vertex, a Fortune 500, global biotechnology company. She trained in internal medicine and nephrology before entering the biopharmaceutical industry, where she
Reshma is the Chief Executive Officer and President at Vertex, a Fortune 500, global biotechnology company. She trained in internal medicine and nephrology before entering the biopharmaceutical industry, where she
Patricia K. Collawn is the CEO of PNM Resources, Inc., an energy holding company providing electricity and energy services. Collawns leadership is marked by a commitment to operational excellence, sustainability,
Patricia K. Collawn is the CEO of PNM Resources, Inc., an energy holding company providing electricity and energy services. Collawns leadership is marked by a commitment to operational excellence, sustainability,
Patricia K. Poppe is the Chief Executive Officer of San Francisco-based PG&E Corporation. Poppe joined PG&E in January 2021 after five years as President and CEO of CMS Energy and
Patricia K. Poppe is the Chief Executive Officer of San Francisco-based PG&E Corporation. Poppe joined PG&E in January 2021 after five years as President and CEO of CMS Energy and
Paula Ragan, Ph.D., is the CEO of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for rare and serious diseases. Dr. Ragans leadership is characterized by a
Paula Ragan, Ph.D., is the CEO of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for rare and serious diseases. Dr. Ragans leadership is characterized by a
Phebe N. Novakovic has been the Chairman and Chief Executive Officer of General Dynamics since 2013. She was the President and Chief Operating Officer of General Dynamics in 2012, Executive
Phebe N. Novakovic has been the Chairman and Chief Executive Officer of General Dynamics since 2013. She was the President and Chief Operating Officer of General Dynamics in 2012, Executive